Protecting Personal Data and Confidential Information in EU Clinical Trials

In the highly regulated environment of EU clinical trials, safeguarding personal data and commercially confidential information (CCI) is critical – not only for legal compliance, but also for maintaining trust among stakeholders. For companies leveraging translation and localization services to support global clinical research, understanding how these services intersect with data protection regulations such as the GDPR and EMA policies is essential. Janus Worldwide plays a pivotal role in ensuring the confidentiality and security of sensitive information through industry-leading localization solutions.

GDPR applies universally within the EU, requiring that personal data be processed securely and transparently, regardless of language or jurisdiction. Clinical trial documentation, including consent forms, patient information sheets, and regulatory submissions, often needs to be translated into multiple languages to facilitate global research. At Janus Worldwide, we ensure that data privacy standards are consistently maintained across all language versions, supporting seamless compliance with the GDPR.

EMA’s Policy 0070 mandates the secure handling of CCI during regulatory interactions. For Janus Worldwide, this means implementing strict measures to prevent inadvertent disclosure of sensitive information during translation and communication with regulatory authorities. Our team follows best practices in document security, ensuring the integrity of every translated document.

The Critical Role of Translation and Localization in Data Protection

1. Accurate and Consistent Translation of Privacy and Confidentiality Clauses
   At Janus Worldwide, our translation experts ensure that privacy notices, consent forms, and confidentiality clauses are accurately translated, preserving their legal intent and clarity across languages. Any misinterpretation could lead to non-compliance or data breaches, which is why our linguistic teams are trained to handle legal and regulatory terms with precision.
2. Managing Confidential Information During Translation Processes
   • Controlled Access: we restrict access to sensitive documents to authorized personnel only, using secure systems to ensure confidentiality at all stages of the translation process.
   • Secure Storage and Transmission: Janus Worldwide uses encrypted channels to send and receive documents, ensuring that sensitive information remains protected throughout its lifecycle.
   • Non-Disclosure Agreements (NDAs): we establish NDAs with all our translation vendors to reinforce confidentiality commitments, ensuring that all parties are held to the highest standards of data protection.

3. Handling Multilingual Data with Care
   When translating datasets or reports containing personal data or CCI, we employ anonymization and pseudonymization techniques where appropriate. This approach is supported by Janus Worldwide’s advanced translation platforms, such as Global Technology Platform (GTP), which streamline and secure the translation process.
4. Training and Awareness
   Our translation teams at Janus Worldwide are regularly trained on GDPR principles and EMA confidentiality requirements. We emphasize the importance of data security, empowering our teams to handle clinical trial materials with the utmost sensitivity.

While translation services help increase transparency by facilitating global dissemination of clinical trial information, Janus Worldwide understands that maintaining confidentiality is equally critical. We apply the following practices to protect sensitive data:

• Redact or anonymize sensitive information before translation when possible.
• Use secure, controlled environments for handling confidential documents.
• Coordinate closely with regulatory teams to ensure that translations meet local legal requirements without compromising CCI.

Translation and localization services are essential to global clinical trials, but they also come with substantial responsibilities regarding data privacy and confidentiality. At Janus Worldwide, we provide translation solutions that align with GDPR and EMA policies by implementing secure handling of documents, clear confidentiality agreements, and rigorous staff training. Our tools, such as MAIA and GTP, enable us to offer high-quality, compliant translations while safeguarding personal data and CCI.

In a landscape where regulatory compliance and data security are non-negotiable, Janus Worldwide is a trusted partner. Our deep understanding of EU regulations and our commitment to maintaining confidentiality makes us an invaluable ally in advancing ethical and compliant clinical research across borders.